BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30094793)

  • 1. Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP).
    Camps Herrero C; Reina Zoilo JJ; Monge Martín D; Caballero Martínez F; Guillem Porta V; Aranda Aguilar E; Carrato Mena A; Díaz-Rubio García E; García-Foncillas López J; Feijóo Saus M; López López R
    Clin Transl Oncol; 2019 Mar; 21(3):380-390. PubMed ID: 30094793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
    Canal-Sotelo J; Trujillano-Cabello J; Larkin P; Arraràs-Torrelles N; González-Rubió R; Rocaspana-Garcia M; Barallat-Gimeno E
    BMC Palliat Care; 2018 May; 17(1):81. PubMed ID: 29807537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting.
    Baek SK; Kim DY; Kang SY; Sym SJ; Kim YS; Lee JY
    Cancer Res Treat; 2016 Apr; 48(2):768-74. PubMed ID: 26511815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Ferrero VT; Oset MM; Masferrer JP; Pardo EH; Sorolla EJ; Largo SC;
    Clin Transl Oncol; 2019 Dec; 21(12):1707-1711. PubMed ID: 30949931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).
    Porta-Sales J; Pérez C; Escobar Y; Martínez V
    Clin Transl Oncol; 2016 Sep; 18(9):945-54. PubMed ID: 26693731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough cancer pain: The importance of the right treatment at the right time.
    O'Hagan P; Mercadante S
    Eur J Pain; 2018 Aug; 22(7):1362-1374. PubMed ID: 29635732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
    Boceta J; De la Torre A; Samper D; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2016 Nov; 18(11):1088-1097. PubMed ID: 26856600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.
    Mercadante S; Adile C; Masedu F; Valenti M; Aielli F
    J Pain Symptom Manage; 2019 May; 57(5):966-970. PubMed ID: 30822530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice Patterns in Distinguishing Between Background Pain and Breakthrough Pain During Patient Education: a Korean Physician Survey.
    Shin J; Kim DY; Lee J; Choi YS; Hwang IG; Baek SK; Seo MS; Shim JY
    J Cancer Educ; 2018 Apr; 33(2):284-292. PubMed ID: 27623849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.
    López López R; Camps Herrero C; Khosravi-Shahi P; Guillem Porta V; Carrato Mena A; Garcia-Foncillas J; Cruz Hernández JJ; Gascón Vilaplana P; Antón Torres A; Diaz-Rubio E; Feyjoo Saus M; Aranda Aguilar E
    Clin Transl Oncol; 2018 May; 20(5):613-618. PubMed ID: 28975575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 14. Breakthrough cancer pain: review and calls to action to improve its management.
    Camps Herrero C; Batista N; Díaz Fernández N; Escobar Álvarez Y; Gonzalo Gómez A; Isla Casado D; Salud A; Terrasa Pons J; Guillem Porta V
    Clin Transl Oncol; 2020 Aug; 22(8):1216-1226. PubMed ID: 32002739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment.
    Reis-Pina P; Acharya A; Barbosa A; Lawlor PG
    Pain Res Manag; 2020; 2020():6190862. PubMed ID: 32566062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and practice of the management of breakthrough cancer pain among general practitioners providing palliative care in Shanghai, China: a cross-sectional survey.
    Yu Y; Zhang P; Chen D; Jiang SF
    BMJ Open; 2023 Sep; 13(9):e073670. PubMed ID: 37770268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing Differences in Perception between Oncologists and Patients to Adapt Pharmacological Treatment for Breakthrough Cancer Pain: Observational ADAPTATE Study.
    Cabezón-Gutiérrez L; Álamo-González C; Monge-Martín D; Caballero-Martínez F
    J Palliat Med; 2022 Jun; 25(6):925-931. PubMed ID: 35049361
    [No Abstract]   [Full Text] [Related]  

  • 18. Breakthrough cancer pain: twenty-five years of study.
    Mercadante S; Portenoy RK
    Pain; 2016 Dec; 157(12):2657-2663. PubMed ID: 27653423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
    Katz NP; Gajria KL; Shillington AC; Stephenson JJ; Harshaw Q
    Postgrad Med; 2017 Jan; 129(1):32-39. PubMed ID: 27846789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.